최소 단어 이상 선택하여야 합니다.
최대 10 단어까지만 선택 가능합니다.
다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
NTIS 바로가기International journal of pharmaceutics, v.490 no.1/2, 2015년, pp.265 - 272
Lim, J.L. , Ki, M.H. , Joo, M.K. , An, S.W. , Hwang, K.M. , Park, E.S.
Liquid crystal (LC) technology has attracted much interest for new injectable sustained-release (SR) formulations. In this study, an injectable liquid crystal-forming system (LCFS) including entecavir was prepared for the treatment of hepatitis B. In particular, an anchoring effect was introduced be...
Colloids Surf. B: Biointerfaces Amar-Yuli 43 72 2005 10.1016/j.colsurfb.2005.03.011 Transitions induced by solubilized fat into reverse hexagonal mesophases
Acc. Chem. Res. Angelova 44 147 2011 10.1021/ar100120v Self-assembled multicompartment liquid crystalline lipid carriers for protein, peptide, and nucleic acid drug delivery
Biomaterials Appel 33 4646 2012 10.1016/j.biomaterials.2012.02.030 Sustained release of proteins from high water content supramolecular polymer hydrogels
J. Pept. Sci. Astaneh 13 649 2007 10.1002/psc.894 Zinc-leuprolide complex: preparation, physicochemical characterization and release behavior from in situ forming implant
Baraclude Scientific Discussion, European Medicines Agency ⓒEMEA 2006.
Int. J. Pharm. Barauskas 391 284 2010 10.1016/j.ijpharm.2010.03.016 Interactions of lipid-based liquid crystalline nanoparticles with model and cell membranes
Biochemistry Bergers 21 4641 1993 10.1021/bi00068a023 The role of protein charge in protein-lipid interactions. pH-dependent changes of the electrophoretic mobility of liposomes through adsorption of water-soluble, globular proteins
Int. J. Pharm. Boyd 309 218 2006 10.1016/j.ijpharm.2005.11.033 Lyotropic liquid crystalline phases formed from glycerate surfactants as sustained release drug delivery systems
J. Liposome Res. Boyd 19 12 2009 10.1080/08982100802691983 Nonlamellar liquid crystalline nanostructured particles: advances in materials and structure determination
J. Control. Release Clogston 102 441 2005 10.1016/j.jconrel.2004.10.007 Controlling release from the lipidic cubic phase by selective alkylation
Pharm. Dev. Technol. Desai 18 1305 2013 10.3109/10837450.2012.672991 Solubilization of entecavir by povidone to overcome content uniformity challenges for low-dose tablet formulations
Int. J. Pharm. Farkas 340 71 2007 10.1016/j.ijpharm.2007.03.038 Study on the release of chlorhexidine base and salts from different liquid crystalline structures
Langmuir Fong 26 6136 2010 10.1021/la100644s Plasmonic nanorods provide reversible control over nanostructure of self-assembled drug delivery materials
Spectrochim. Acta Part A: Mol. Biomol. Spectrosc. Gao 126 178 2014 10.1016/j.saa.2014.02.009 Label-free silver nanoparticles for the naked eye detection of entecavir
Drug Discov. Today Guo 15 23 2010 10.1016/j.drudis.2010.09.006 Lyotropic liquid crystal systems in drug delivery
Colloids Surf. A: Physicochem. Eng. Aspects Gurfinkel 392 322 2011 10.1016/j.colsurfa.2011.10.010 Interactions of surfactants in nonionic/anionic reverse hexagonal mesophases and solubilization of chymotrypsinogen A
Langmuir Gustafsson 13 6964 1997 10.1021/la970566+ Submicron particles of reversed lipid phases in water stabilized by a nonionic amphiphilic polymer
J. Control. Release He 127 189 2008 10.1016/j.jconrel.2008.01.005 In situ gelling stimuli-sensitive block copolymer hydrogels for drug delivery
Expert Opin. Invest. Drugs Honkoop 12 683 2003 10.1517/13543784.12.4.683 Entecavir: a potent new antiviral drug for hepatitis B
Hyde 299 2001 Handbook of Applied Surface and Colloid Chemistry Identification of lyotropic liquid crystalline mesophases
Antimicrob. Agents Chemother. Innaimo 41 1444 1997 10.1128/AAC.41.7.1444 Identification of BMS-200475 as a potent and selective inhibitor of hepatitis B virus
Bioconjugate Chem. Khiati 20 1765 2009 10.1021/bc900163s Anionic nucleotide-lipids for in vitro DNA transfection
J. Control. Release Ki 185 62 2014 10.1016/j.jconrel.2014.04.034 A new injectable liquid crystal system for one month delivery of leuprolide
Int. J. Pharm. Kuntsche 417 1 2011 10.1016/j.ijpharm.2011.02.001 Cryogenic transmission electron microscopy (cryo-TEM) for studying the morphology of colloidal drug delivery systems
J. Colloid Interface Sci. Lynch 260 404 2003 10.1016/S0021-9797(02)00016-4 Enhanced loading of water-soluble actives into bicontinuous cubic phase liquid crystals using cationic surfactants
Int. J. Pharm. Namur 273 1 2004 10.1016/j.ijpharm.2003.12.003 Lactic acid triggers, in vitro, thiomersal to degrade protein in the presence of PLGA microspheres
Drug Deliv. Transl. Res. Nguyen 1 429 2011 10.1007/s13346-011-0045-z Nanostructured reverse hexagonal liquid crystals sustain plasma concentrations for a poorly water-soluble drug after oral administration
Adv. Drug Deliv. Rev. Okada 28 43 1997 10.1016/S0169-409X(97)00050-1 One- and three-month release injectable microspheres of the LH-RH super agonist leuprorelin acetate
Clin. Med. Ther. Palumbo 1 11 2009 Pharmacotherapy of chronic hepatitis B with entecavir
J. Am. Chem. Soc. Pindzola 125 2940 2003 10.1021/ja0208106 Cross-linked normal hexagonal and bicontinuous cubic assemblies via polymerizable gemini amphiphiles
Biomaterials Qiu 21 223 2000 10.1016/S0142-9612(99)00126-X The phase diagram of the monoolein/water system: metastabilityand equilibrium aspects
Curr. Opin. Colloid Interface Sci. Sagalowicz 11 224 2006 10.1016/j.cocis.2006.07.002 Investigating reversed liquid crystalline mesophases
Adv. Drug Deliv. Rev. Shah 47 229 2001 10.1016/S0169-409X(01)00108-9 Cubic phase gels as drug delivery systems
Spicer 2003 Personal Care Delivery Systems and Formulations Bicontinuous cubic liquid crystalline phase and cubosome personal care delivery systems
Adv. Drug Deliv. Rev. Svenson 64 102 2012 10.1016/j.addr.2012.09.030 Dendrimers in biomedical applications-reflections on the field
Expert Opin. Drug Deliv. Teutonico 9 343 2012 10.1517/17425247.2012.662484 Leuprolide acetate: pharmaceutical use and delivery potentials
Pharm. Res. Weert 17 1159 2000 10.1023/A:1026498209874 Protein instability in poly(lactic-co-glycolic acid) microparticles
Expert Opin. Drug Deliv. Wilson 16 1 2007 Leuprolide acetate: a drug of diverse clinical applications
J. Clin. Pharmacol. Yan 46 1250 2006 10.1177/0091270006293304 Entecavir pharmacokinetics, safety, and tolerability after multiple ascending doses in healthy subjects
Colloids Surf. B: Biointerfaces Zakanda 86 176 2011 10.1016/j.colsurfb.2011.03.039 Penetration behaviour of alkylbetainate chlorides into lipid monolayers
*원문 PDF 파일 및 링크정보가 존재하지 않을 경우 KISTI DDS 시스템에서 제공하는 원문복사서비스를 사용할 수 있습니다.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.